BlackRock Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

BlackRock Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.05M	Buy	151,002 +363	+0.2%	+$2.32K	﹤0.01%	2669
2016 Q3	$767K	Sell	150,639 -410	-0.3%	-$2.45K	﹤0.01%	2826
2016 Q2	$902K	Buy	151,049 +144,722	+2,287%	+$803K	﹤0.01%	2706
2016 Q1	$29K	Sell	6,327 -202	-3%	-$899	﹤0.01%	3310
2015 Q4	$29K	Buy	6,529 +211	+3%	+$891	﹤0.01%	3352
2015 Q3	$20K	Hold	6,318	–	–	﹤0.01%	3440
2015 Q2	$19K	Sell	6,318 -97,272	-94%	-$273K	﹤0.01%	3454
2015 Q1	$306K	Buy	103,590 +3,845	+4%	+$12.6K	﹤0.01%	3126
2014 Q4	$443K	Buy	99,745 +464	+0.5%	+$2.21K	﹤0.01%	3065
2014 Q3	$511K	Buy	99,281 +2,209	+2%	+$11.8K	﹤0.01%	2958
2014 Q2	$510K	Buy	+97,072	New	+$420K	﹤0.01%	3031

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock Investment Management's ENZ Position: Q4 2016 in Review

BlackRock Investment Management increased its Enzo Biochem, Inc. (ENZ) stake by 0.24% in Q4 2016, buying an estimated $2.32K and bringing the position to 151,002 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2669.

BlackRock Investment Management first reported a position in ENZ in Q2 2014 and has held it in 11 quarters since. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

BlackRock Investment Management held 151,002 shares of Enzo Biochem, Inc. worth $1.05M as of Q4 2016.
BlackRock Investment Management bought 363 Enzo Biochem, Inc. shares in Q4 2016, an estimated $2.32K.
Enzo Biochem, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2669 holding.
BlackRock Investment Management first reported a position in Enzo Biochem, Inc. in Q2 2014 and has held it in 11 quarters since.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.